This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Rosenberg, S. A. Search for Related Content PubMed PubMed Citation Articles by Rosenberg, S. A.

Hodgkin's Disease: Challenges for the Future¹

Division of Oncology, Stanford University School of Medicine, Stanford, California 94305

Clinical investigators of Hodgkin's disease of the recent past have reason to be proud. Tens of thousands of individuals, many of them young, fertile, and productive, have been cured of their life-threatening disease. There are few better examples control of Hodgkin's disease by improved diagnostic methods and the appropriate use of radiation and chemotherapy.

Yet the clinical investigator of today cannot be satisfied with these successes. The treatment required for high cure rates remains empirical, difficult, and costly. The goal must be to prevent or reverse this fascinating disease, utilizing specific therapy designed from a knowledge of the cause and pathogenesis of the disease. There are sufficient biological clues and methodologies to predict that this will be possible, and in the decade of the 1990s!

¹ Studies reported herein were supported in part by Grant CA-34233 from the National Cancer Institute, Bethesda, MD.

Received 9/15/88. Revised 11/ 3/88. Accepted 11/15/88.